Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.
Let's find out more about cancer: symptoms, treatment, causes, and how to prevent it. Breast cancer is a potentially serious disease if not detected and treated in time. As explained by the AIRC ...
Results that may be inaccessible to you are currently showing.